Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1683307

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 December 2023 to Question 5383 on NHS: Standards, what steps her Department is taking to to ensure quality improvement across (a) NHS England, (b) Integrated Health and Care Boards and (c) NHS Hospital Trusts.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	10452
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>NHS Improving Patient Care Together is the single improvement approach to support all National Health Service organisations, systems, and providers at every level, including NHS England, to have the skills and techniques to deliver continuous improvement. Information and resources are available at the following link:</p><p> </p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.england.nhs.uk%2Fnhsimpact%2Fabout-nhs-impact%2F&amp;data=05%7C02%7CFrancesca.Day%40dhsc.gov.uk%7C679a326c09594acdc07e08dbfc005597%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638380850600125951%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=3fC5Kj0WuJz7kdclLWI9HRzV20VSjoxtP%2BMzeb3RHbk%3D&amp;reserved=0" target="_blank">https://www.england.nhs.uk/nhsimpact/about-nhs-impact/</a></p><p> </p><p>The performance of integrated care boards (ICBs) in the exercise of their functions is assessed, annually, by NHS England. The NHS Oversight Framework describes NHS England’s approach to the oversight of ICBs, and is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/nhs-oversight-framework/" target="_blank">https://www.england.nhs.uk/nhs-oversight-framework/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:17:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4124 label Biography information for Chi Onwurah

1683493

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Anaesthesia Associates and Physician Associates: Regulation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with her counterpart in the Welsh government on the regulation of (a) physician associates and (b) anaesthesia associates.
tabling member constituency	Carmarthen East and Dinefwr
tabling member printed	Jonathan Edwards
uin	10443
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Ministers have corresponded with their counterparts in the Welsh Government, alongside those in Scotland and Northern Ireland, in taking forward the work to bring physician associates (PAs) and anaesthesia associates (AAs) into regulation.</p><p>The regulation of PAs and AAs has been subject to extensive public consultation over several years. Throughout the project, officials have engaged thoroughly with stakeholders including the regulators, the devolved administrations, the Professional Standards Authority for Health and Social Care, representative bodies, and service users in developing the policy behind this legislation.</p><p>This engagement has been crucial in shaping both our policy intention and the resultant legislation, to ensure that it remains a practical piece of legislation for the benefit of patient safety and registrants.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:15:38 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3943 label Biography information for Jonathan Edwards

1683497

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to increase the number of people living with diabetes who receive their NICE recommended care processes.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	10448
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Recovery of routine diabetes care following the pandemic is a key priority for the NHS England Diabetes Programme. Transformation funding between 2020/21 and 2022/23 has supported recovery, as such that rates of routine care delivery are now almost back to the pre-pandemic level. Services in the National Health Service are asked to continue this upward trajectory, with a particular focus on ensuring that people from socio-economically deprived areas receive their annual reviews.</p><p> </p><p>According to the report from the fourth quarter of 2022/23, the percentage of people who received all eight National Institute of Health and Care Excellence recommended care processes in England between January 2022 and March 2023 was 40.5% for type 1 diabetes and 57.8% for type 2/other diabetes, 15.3% and 20.6% higher respectively than the same period in the previous year. The percentages remained slightly lower than prior to the COVID-19 pandemic, where in the fourth quarter of 2019/20, they were 42.3% and 58.5%, respectively.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:16:33 answering member 4044 label Biography information for Andrew Stephenson
tabling member	3973 label Biography information for Grahame Morris

1683514

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of pancreatic cancers were diagnosed at an early stage in the most recent year for which information is available.
tabling member constituency	Birmingham, Erdington
tabling member printed	Mrs Paulette Hamilton
uin	10572
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Latest figures from NHS Digital for cancers diagnosed between January and December 2021 show that 25% of pancreatic cancers were diagnosed at Stage 1 and 2.</p><p>NHS England is developing new dedicated urgent diagnostic pathways for these patients so that every cancer patient with concerning, but non-specific symptoms, gets the right tests at the right time in as few visits as possible. There are now 113 of these pathways live, which are seeing more than 5,500 patients per month.</p><p>NHS England is also providing a route into pancreatic cancer surveillance for those at high-risk due to family history or at-risk genetic mutations and have formed an expert group to consider a pathway for Hepato-Pancreato-Biliary cancers, including pancreatic cancer.</p><p>NHS England is funding a new audit into pancreatic cancer to increase the consistency of access to treatments and to stimulate improvements in cancer treatment and outcomes for patients. The Royal College of Surgeons began work on this audit in October 2022 and the first report is expected in October 2024. In addition to this, the Getting it Right First-Time team in NHS England is undertaking a deep dive into pancreatic cancer, which will highlight actions National Health Service providers need to take to improve services, as well as gathering examples of good practice to share.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 10573 question first answered 23/01/2024 09:18:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4938 label Biography information for Mrs Paulette Hamilton

1683515

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase the rate of diagnosis of pancreatic cancers at an early stage.
tabling member constituency	Birmingham, Erdington
tabling member printed	Mrs Paulette Hamilton
uin	10573
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Latest figures from NHS Digital for cancers diagnosed between January and December 2021 show that 25% of pancreatic cancers were diagnosed at Stage 1 and 2.</p><p>NHS England is developing new dedicated urgent diagnostic pathways for these patients so that every cancer patient with concerning, but non-specific symptoms, gets the right tests at the right time in as few visits as possible. There are now 113 of these pathways live, which are seeing more than 5,500 patients per month.</p><p>NHS England is also providing a route into pancreatic cancer surveillance for those at high-risk due to family history or at-risk genetic mutations and have formed an expert group to consider a pathway for Hepato-Pancreato-Biliary cancers, including pancreatic cancer.</p><p>NHS England is funding a new audit into pancreatic cancer to increase the consistency of access to treatments and to stimulate improvements in cancer treatment and outcomes for patients. The Royal College of Surgeons began work on this audit in October 2022 and the first report is expected in October 2024. In addition to this, the Getting it Right First-Time team in NHS England is undertaking a deep dive into pancreatic cancer, which will highlight actions National Health Service providers need to take to improve services, as well as gathering examples of good practice to share.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 10572 question first answered 23/01/2024 09:18:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4938 label Biography information for Mrs Paulette Hamilton

1683516

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help ensure that cancer waiting time targets are met in (a) Birmingham Erdington constituency and (b) England.
tabling member constituency	Birmingham, Erdington
tabling member printed	Mrs Paulette Hamilton
uin	10574
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Reducing cancer treatment waiting times is a priority for the Government. The Department is working jointly with NHS England on implementing the delivery plan for tackling the COVID-19 backlogs in elective care. The Government plans to spend more than £8 billion from 2022/23 to 2024/25 to help drive up and protect elective activity, including cancer diagnosis and treatment activity.</p><p>In the 2023/24 Operational Planning Guidance, NHS England announced it is providing over £390 million in cancer service development funding to cancer alliances to support delivery of the strategy and the operational priorities for cancer which includes increasing and prioritising diagnostic and treatment capacity for cancer.</p><p>Additionally, the Government published the Major conditions strategy case for change and our strategic framework on 14 August 2023 which sets out our approach to making the choices over the next five years that will deliver the most value in facing the health challenges of today and of the decades ahead, including for cancer.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:19:32 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4938 label Biography information for Mrs Paulette Hamilton

1683517

registered interest
date	18/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential merits of publishing a dedicated cancer strategy.
tabling member constituency	Birmingham, Erdington
tabling member printed	Mrs Paulette Hamilton
uin	10575
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>On 24 January 2023, the Government announced plans to publish the Major Conditions Strategy, which will focus on tackling the six major conditions groups: cancers, mental ill-health, cardiovascular disease including stroke and diabetes, dementia, chronic respiratory diseases, and musculoskeletal disorders, that account for around 60% of ill-health and early death in England. Addressing cancer together with other major conditions will allow the Department and NHS England to focus on similarities in approach, ensuring care is better centred around the patient.</p><p>Following the call for evidence for a 10-year cancer plan in 2022, the Department received over 5,000 submissions. These findings are being fed into the development of the Major Conditions Strategy.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/01/2024 09:22:15 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4938 label Biography information for Mrs Paulette Hamilton

1682842

registered interest
date	17/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Attention Deficit Hyperactivity Disorder: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure there is a sufficient and reliable supply of medicines to help patients suffering from ADHD.
tabling member printed	Lord Allen of Kensington
uin	HL1670
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>Disruptions to the supply of medicines used for the management of attention deficit hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working closely with the respective manufacturers and some issues have now been resolved. However, we know that there continue to be disruptions to the supply of some other medicines, which should largely resolve by April or May 2024. We have also added ADHD products to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom to protect UK supplies for patients.</p><p>There is a team within the Department that deals specifically with medicine supply problems arising both in the community and in hospitals. It has well-established procedures to manage medicine supply issues, whatever the cause, and help to prevent shortages and minimise risks to patients by working closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, and others operating in the supply chain.</p><p>We understand how frustrating and distressing medicine supply issues can be and we want to assure patients that we are working with the respective manufacturers to resolve the issues with ADHD medicine supply in the UK as soon as possible and to help ensure patients are able to access these medicines in the short and long term.</p> answering member printed Lord Markham question first answered 23/01/2024 15:32:48 answering member 4948 label Biography information for Lord Markham
tabling member	4304 label Biography information for Lord Allen of Kensington

1682859

registered interest
date	17/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Women
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that mental health services are accessible to women in all regions.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10169
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>The NHS Long Term Plan commits to investing £2.3 billion of extra funding a year in expanding and transforming mental health services by March 2024, enabling an extra two million people, including women, to be treated by mental health services within the National Health Service. In addition, we are investing £25 million to expand women’s health hubs.</p><p>We are expanding access to psychological and talking therapies within specialist perinatal mental health services. This expansion includes new Maternal Mental Health Services, which bring together psychological therapy, maternity services and reproductive health for women who have mental health needs following trauma or loss related to their maternity experience. These will be available across the whole of England by March 2024.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 23/01/2024 16:16:56 answering member 4492 label Biography information for Maria Caulfield
tabling member	4471 label Biography information for Rachael Maskell

1682862

registered interest
date	17/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus : Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to ensure people diagnosed as medically vulnerable can access covid-19 vaccination regardless of the medication they are taking.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	10172
answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>The primary aim of the COVID-19 vaccination programme remains the prevention of severe disease, including hospitalisation and death, arising from COVID-19. The risk of developing severe COVID-19 continues to be strongly associated with increasing age and underlying health conditions.</p><p>In line with the Joint Committee on Vaccination and Immunisation advice accepted by the Government, the offer of vaccination is therefore focused on those at greatest risk. In autumn 2023, this included all adults aged 65 years old and over and those aged six months to 64 years old in a clinical risk group, as defined in the UK Health Security Agency’s Green Book on immunisation.</p><p>This offer was open to all eligible individuals regardless of medication status. Clinicians can advise on individual circumstances, and anyone concerned should seek relevant advice.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 23/01/2024 16:27:33 answering member 4492 label Biography information for Maria Caulfield
tabling member	4471 label Biography information for Rachael Maskell